Schroder Investment Management Group
FLXN

Schroder Investment Management Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Schroder Investment Management Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-640,313
Closed -$7.39M – 1639
2020
Q4 		$7.39M Buy
640,313
+5,322
+0.8% +$61.8K 0.01% 705
2020
Q3 		$6.43M Buy
634,991
+14,127
+2% +$173K 0.01% 682
2020
Q2 		$8.16M Sell
620,864
-11,959
-2% -$124K 0.01% 599
2020
Q1 		$4.9M Buy
632,823
+22,633
+4% +$341K 0.01% 673
2019
Q4 		$12.6M Buy
610,190
+37,382
+7% +$630K 0.02% 593
2019
Q3 		$7.97M Sell
572,808
-564,944
-50% -$6.7M 0.01% 667
2019
Q2 		$14M Buy
1,137,752
+639,344
+128% +$7.38M 0.01% 654
2019
Q1 		$6.22M Sell
498,408
-57,943
-10% -$774K 0.01% 662
2018
Q4 		$6.3M Buy
556,351
+70,621
+15% +$1.11M 0.01% 638
2018
Q3 		$9.09M Sell
485,730
-16,612
-3% -$382K 0.02% 617
2018
Q2 		$12.7M Sell
502,342
-10,135
-2% -$263K 0.02% 561
2018
Q1 		$11.5M Sell
512,477
-4,504
-0.9% -$110K 0.02% 578
2017
Q4 		$12.9M Buy
516,981
+89,806
+21% +$2.2M 0.02% 594
2017
Q3 		$10.2M Sell
427,175
-82,252
-16% -$1.93M 0.02% 624
2017
Q2 		$10.5M Buy
509,427
+115,413
+29% +$2.4M 0.02% 596
2017
Q1 		$10.7M Sell
394,014
-196,764
-33% -$4.02M 0.02% 597
2016
Q4 		$11.2M Buy
590,778
+259,248
+78% +$4.95M 0.02% 594
2016
Q3 		$6.48M Hold
331,530
– – 0.01% 695
2016
Q2 		$4.96M Hold
331,530
– – 0.01% 727
2016
Q1 		$2.98M Sell
331,530
-138,670
-29% -$1.68M 0.01% 768
2015
Q4 		$9.06M Buy
470,200
+81,500
+21% +$1.42M 0.02% 642
2015
Q3 		$5.78M Buy
388,700
+23,000
+6% +$540K 0.01% 713
2015
Q2 		$7.61M Buy
365,700
+100,800
+38% +$2.03M 0.02% 682
2015
Q1 		$5.93M Buy
264,900
+4,900
+2% +$113K 0.01% 735
2014
Q4 		$5.25M Buy
+260,000
New +$4.71M 0.01% 778

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Schroder Investment Management Group's FLXN Position: Q1 2021 in Review

Schroder Investment Management Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 640,313 shares — an estimated $7.39M sold.

Schroder Investment Management Group first reported a position in FLXN in Q4 2014 and held it in 25 quarters. The position peaked at $14M in Q2 2019. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

  • Schroder Investment Management Group reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 640,313 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $7.39M.
  • Schroder Investment Management Group first reported a position in Flexion Therapeutics, Inc. in Q4 2014 and held it in 25 quarters.
  • Schroder Investment Management Group's Flexion Therapeutics, Inc. position peaked at $14M in Q2 2019.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on Schroder Investment Management Group's 13F filing for Q1 2021, filed 17 May 2021.